Valvular Aortic Stenosis Prognosis Study
Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Aug 9, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Valvular Aortic Stenosis Prognosis Study is looking to understand the long-term outcomes for patients with a condition called aortic stenosis, which is a narrowing of the heart's aortic valve. This study will examine both patients who have symptoms and those who do not, to better understand how this condition affects them over time. Researchers will use heart ultrasound tests (called echocardiograms) to gather important information about the condition and how it might progress.
If you're between the ages of 65 and 74 and have been diagnosed with aortic stenosis in the past or have had an echocardiogram showing a narrowing of the aortic valve, you might be eligible to participate. However, you won't be able to join if you previously had surgery on your aortic valve or if you choose not to participate. For those who do join, the study will involve reviewing medical records and echocardiogram results collected over several years, helping to provide valuable insights into this common heart condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Retrospectively, all patients examined from January 1, 2000 to November 2014 will be included in the echocardiography laboratory whose objective examination is a narrowing of the aortic valve (maximum transaortic velocity ≥2.5 m / s).
- • Aortic stenosis may be known in the past.
- Exclusion Criteria:
- • Refusal of the patient to participate in the study.
- • Patients who have previously had aortic valve surgery before being examined in the echocardiography laboratory.
- • Patients who can not be contacted or who do not respond will not be included in the database.
About Centre Hospitalier Universitaire, Amiens
The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, , France
Patients applied
Trial Officials
Christophe TRIBOUILLOY, MD, PhD
Principal Investigator
CHU AMIENS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials